Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipifarnib in Pediatric NF1 with Plexiform Neurofibromas
NCT00021541Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2001
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tipifarnib in neurofibromatosis type 1 (NF1), plexiform neurofibroma (PN), sponsored by National Cancer Institute. Started Jul 2001; status: completed.
02
Drugs
tipifarnib
03
Conditions
neurofibromatosis type 1 (NF1)plexiform neurofibroma (PN)
Beyond the preview
Go deeper on NCT00021541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00021541.